Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transl Med
Main Authors: Shishido, Stephanie N., Carlsson, Anders, Nieva, Jorge, Bethel, Kelly, Hicks, James B., Bazhenova, Lyudmila, Kuhn, Peter
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714097/
https://ncbi.nlm.nih.gov/pubmed/31462312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2035-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares